Growth hormone signaling in muscle and adipose tissue of obese human subjects: Associations with measures of body composition and interaction with resveratrol treatment

Berthil F. Clasen, Morten M. Poulsen, Carlos Escande, Steen B. Pedersen, Niels Møller, Eduardo N. Chini, Niels Jessen, Jens O.L. Jørgensen

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Context: Growth hormone (GH) secretion is reduced in obesity, despite normal serum insulin-like growthfactor I (IGF-1) levels, but the association between obesity and the GH signaling is unknown. Furthermore, SIRT1, an nicotinamide adenine dinucleotide-dependent protein deacetylase, reduces hepatic IGF-1 production in mice via blunting of GH-induced STAT5 signaling. Objective: To study GH signaling in muscle and fat in obese subjects and the interaction with concomitant administration of the putative SIRT1 activator resveratrol, and to assess the effects of inhibiting or knocking down SIRT1 on GH regulated genes in vitro. Design and Participants: Twenty-four obese males were examined in a randomized, double blinded, parallel-group study with resveratrol or placebo treatment for 5 weeks followed by a GH bolus. Muscle and fat biopsies were collected before and after GH. Body composition was assessed by DEXA and MRI. Main Outcome Measure: (1) Effect of body composition and age on GH-stimulated STAT5b phosphorylation and IGF-1, SOCS2, and CISH mRNA in muscle and fat. (2) The impact of resveratrol treatment on GH activity. (3) Impact of inhibiting or knocking down SIRT1 on effects of GH in vitro. Results: Significant GH-induced STAT5b phosphorylation in muscle and fat in obese subjects was recorded together with increased CISH and SOCS2 mRNA. GH-induced STAT5b phosphorylation in muscle correlated positively with age [r = 0.53, p<0.01], but not with body composition. Resveratrol administration had no impact on body composition, serum IGF-1, or GH signaling in vivo, and SIRT1 knock down or inhibition did not affect GH signaling in vitro. Conclusion: (1) GH induced STAT5b phosphorylation is detectable in muscle and fat in adult males with simple obesity, but is not determined by body composition. (2) Resveratrol supplementation does not impact circulating IGF-1 levels or GH signaling inhumanmuscle and fat. (3) Our data speak against a major impact of SIRT1on GH action in human subjects.

Original languageEnglish (US)
Pages (from-to)E2565-E2573
JournalJournal of Clinical Endocrinology and Metabolism
Volume99
Issue number12
DOIs
StatePublished - Dec 1 2014

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Fingerprint Dive into the research topics of 'Growth hormone signaling in muscle and adipose tissue of obese human subjects: Associations with measures of body composition and interaction with resveratrol treatment'. Together they form a unique fingerprint.

Cite this